Connect with us

Business

Third member of US FDA advisory panel resigns over Alzheimer’s drug approval – Fox Business

Published

on

Article feature image
ADVERTISEMENT

A third member of a panel of outside advisers to the U.S. Food and Drug Administration has resigned in protest over the agency’s decision to approve Biogen Inc’s Alzheimer’s disease treatment despite the committee’s recommendation against doing so.
Aaron…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Napa Valley Feud Pits Real-Estate Startup Against Homeowners – The Wall Street Journal
Article feature image
Georgia crypto investor claims he woke up a trillionaire — after investing $20 – Fox Business
Article feature image
Power Restored for Thousands of Customers in Parts of East Bay: PG&E – NBC Bay Area